Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 11 (8), e1005409

Putting the Brakes on Huntington Disease in a Mouse Experimental Model


Putting the Brakes on Huntington Disease in a Mouse Experimental Model

Jane C Kim et al. PLoS Genet.

Conflict of interest statement

The authors have declared that no competing interests exist.


Fig 1
Fig 1. Inhibiting somatic expansions delays onset of disease in a Huntington mouse model.
(A) Expanded (CAG)n repeats are more susceptible to undergoing further expansions, contributing to two distinct aspects of their instability. Intergenerational transmission (vertical axis) is the general increase in repeat length (m) from parent to offspring, which has been found to be dependent on MutSβ in mice. Somatic expansions (horizontal axis) are an increase in repeat length beyond the inherited length throughout the lifetime of an individual (x) and are dependent on both MutSβ and 8-oxoguanine glycosylase (OGG1) in mice. Somatic expansions exhibit tissue-specific differences and, in HD, occur predominantly in the brain (dotted oval). The absence of OGG1 significantly delays the age of disease onset in Hdh mice. This delayed onset of disease symptoms is recapitulated by inhibiting somatic expansion with a ROS scavenger, XJB-5-131. (B) Aberrant repair of DNA oxidative damage at (CAG)n repeats promotes somatic expansions. Initiation of 8-oxoguanine (8-oxoG) base excision repair by OGG1 leads to a nick in the damaged DNA strand. Subsequent strand-displacement synthesis by DNA polymerase β creates a 5ʹ-flap. A hairpin formed by CAG repeats in this flap could be stabilized by MutSβ and incorporated into the repaired DNA to generate an expansion. This expanded region is further subjected to ROS, possibly generating “toxic oxidation cycles” (dotted line).

Comment on

Similar articles

See all similar articles


    1. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971–983. - PubMed
    1. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, et al. (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4: 398–403. - PubMed
    1. Zoghbi HY, Orr HT (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23: 217–247. - PubMed
    1. Mirkin SM (2007) Expandable DNA repeats and human disease. Nature 447: 932–940. - PubMed
    1. Usdin K, House NC, Freudenreich CH (2015) Repeat instability during DNA repair: Insights from model systems. Crit Rev Biochem Mol Biol 50: 142–167. 10.3109/10409238.2014.999192 - DOI - PMC - PubMed

Publication types